Privacy Statement
Effective Date: 27 August 2025
Company Name: Medlab Group Inc
Website: www.medlab.group
1. Commitment to Privacy
Medlab Group Inc (“Company,” “we,” “our,” or “us”) is committed to protecting the privacy and confidentiality of individuals who interact with our website, participate in our clinical research, or engage with our business. As a biotechnology company listed on the New York Stock Exchange (NYSE), we uphold the highest ethical standards in research, comply with all applicable U.S. and international privacy laws, and operate in accordance with the principles of Good Clinical Practice (GCP), FDA regulations, and other relevant regulatory frameworks.
2. Scope of This Privacy Statement
This Privacy Statement explains how we collect, use, disclose, and safeguard information obtained through:
Our corporate website and digital platforms.
Participation in our clinical trials or other research initiatives.
Communications related to publications, regulatory submissions, and investor disclosures.
3. Information We Collect
We may collect the following categories of information:
Personal Identifiable Information (PII): Name, email address, phone number, professional affiliation, or other information you voluntarily provide through forms or inquiries.
Clinical Trial Data: For research participants, we may collect health information, medical history, biomarker data, and other sensitive data in compliance with informed consent agreements, Institutional Review Board (IRB) approvals, FDA regulations, and applicable data protection laws (including HIPAA, GDPR where applicable).
Technical Data: IP addresses, browser type, device information, and website usage statistics.
Regulatory & Compliance Data: Information necessary for FDA submissions, scientific publications, and SEC-required disclosures.
4. How We Use Information
We use collected information for the following purposes:
To operate and improve our website and services.
To manage and conduct ethical human clinical trials.
To support FDA submissions, regulatory filings, and drug approval processes.
To produce peer-reviewed publications and share validated scientific findings.
To comply with legal, regulatory, and reporting obligations as a publicly listed company.
To communicate with patients, clinicians, researchers, investors, and the public.
5. Protection of Clinical Trial Participants
If you are a participant in one of our clinical trials:
Your information is used only for approved research purposes outlined in your Informed Consent Form (ICF).
Data is de-identified and coded whenever possible to protect your privacy.
Access to identifiable health information is strictly limited to authorized personnel and regulators.
Results of trials may be published in scientific journals or reported to regulatory authorities (e.g., FDA, NIH, EMA) in compliance with legal obligations, but without revealing personally identifiable information.
6. Disclosure of Information
We may share information in the following circumstances:
With regulatory authorities such as the FDA, EMA, or equivalent, as required by law.
With Institutional Review Boards (IRBs) and ethics committees overseeing clinical research.
With scientific collaborators, research institutions, and contract research organizations (CROs) assisting in clinical trials.
With auditors, legal advisors, or compliance authorities to ensure transparency and accountability.
As required under applicable securities laws for SEC or NYSE disclosures.
Between the Medlab group of companies, as needed to fulfil their research objectives.
With your explicit consent, when legally required.
We do not sell or rent your personal information to third parties.
7. Data Security
We implement technical, administrative, and organizational safeguards to protect your information against unauthorized access, loss, misuse, or alteration. These safeguards include encryption, secure data storage, restricted access, and compliance with HIPAA, GDPR (where applicable), and U.S. federal regulations on human research protections.
8. International Data Transfers
As a global biotechnology company, data may be transferred to jurisdictions outside your country of residence, including the United States. In such cases, we ensure appropriate legal safeguards, such as Standard Contractual Clauses (SCCs) or equivalent, to protect personal data.
9. Your Rights
Depending on your jurisdiction, you may have the right to:
Access the personal data we hold about you.
Request correction, deletion, or restriction of your information.
Withdraw consent (where applicable).
File a complaint with your local data protection authority.
Clinical trial participants should exercise these rights through the procedures outlined in their Informed Consent Form (ICF).
10. Children’s Privacy
Our Site and services are not intended for individuals under the age of 18, except when participating in approved pediatric clinical trials under parental/guardian consent and ethical oversight.
11. Retention of Data
We retain information for as long as necessary to fulfill research, regulatory, and legal obligations, including FDA and SEC retention requirements, after which it will be securely deleted or anonymized.
12. Updates to This Privacy Statement
We may update this Privacy Statement periodically to reflect changes in our practices or legal obligations. Updates will be posted with a revised “Effective Date.”
13. Contact Information
For questions or concerns about this Privacy Statement, please contact:
Medlab Group Inc
Attn: Privacy Office
330 Seventh Ave, Suite 501
New York, NY, 10001
+1 714 849 4787
hello@medlab.group